Belpointe Asset Management LLC Exact Sciences Corp Transaction History

Belpointe Asset Management LLC

$1.49 Billion
Q3 2024

A detailed history of Belpointe Asset Management LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Belpointe Asset Management LLC holds 61,756 shares of EXAS stock, worth $3.59 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

61,756

Previous 71,837 14.03%

Holding current value

$3.59 Million

Previous $3.04 Million 38.52%

% of portfolio

0.28%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$42.43 - $70.83 $427,736 - $714,037	-10,081 Reduced 14.03%	61,756 $4.2 Million
Q2 2024 Aug 02, 2024	BUY	$41.33 - $74.26 $1.26 Million - $2.27 Million	30,592 Added 74.17%	71,837 $3.04 Million
Q1 2024 May 08, 2024	BUY	$56.27 - $73.77 $1.11 Million - $1.46 Million	19,775 Added 92.11%	41,245 $2.85 Million
Q4 2023 Feb 13, 2024	BUY	$59.06 - $75.72 $937,695 - $1.2 Million	15,877 Added 283.87%	21,470 $1.59 Million
Q3 2023 Nov 15, 2023	BUY	$65.94 - $99.04 $203,886 - $306,231	3,092 Added 123.63%	5,593 $381,000
Q2 2023 Aug 14, 2023	SELL	$62.68 - $95.05 $5.2 Million - $7.88 Million	-82,953 Reduced 97.07%	2,501 $234,000
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $90,746 - $136,090	-1,923 Reduced 2.2%	85,454 $5.79 Million
Q4 2022 Feb 08, 2023	BUY	$30.35 - $53.15 $1.15 Million - $2.02 Million	37,981 Added 76.89%	87,377 $4.33 Million
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $1.46 Million - $2.25 Million	45,533 Added 1178.7%	49,396 $1.61 Million
Q2 2022 Aug 02, 2022	SELL	$35.61 - $76.23 $3,454 - $7,394	-97 Reduced 2.45%	3,863 $152,000
Q1 2022 Apr 28, 2022	BUY	$57.56 - $82.54 $44,896 - $64,381	780 Added 24.53%	3,960 $277,000
Q4 2021 Feb 15, 2022	BUY	$72.5 - $100.68 $77,792 - $108,029	1,073 Added 50.93%	3,180 $247,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $9,655 - $13,273	107 Added 5.35%	2,107 $201,000
Q2 2021 Aug 09, 2021	BUY	$93.66 - $139.27 $92,255 - $137,180	985 Added 97.04%	2,000 $248,000
Q1 2021 May 14, 2021	SELL	$116.57 - $155.01 $170,541 - $226,779	-1,463 Reduced 59.04%	1,015 $134,000
Q4 2020 Feb 16, 2021	SELL	$99.61 - $142.12 $21,914 - $31,266	-220 Reduced 8.15%	2,478 $329,000
Q3 2020 Nov 13, 2020	SELL	$72.92 - $102.01 $16,552 - $23,156	-227 Reduced 9.56%	2,148 $125,000
Q3 2020 Nov 13, 2020	BUY	$72.92 - $102.01 $40,106 - $56,105	550 Added 25.61%	2,698 $275,000
Q2 2020 Jul 20, 2020	BUY	$55.75 - $92.75 $12,655 - $21,054	227 Added 10.57%	2,375 $207,000
Q1 2020 Jul 20, 2020	BUY	$37.9 - $104.44 $28,008 - $77,181	739 Added 52.45%	2,148 $125,000
Q4 2019 Feb 18, 2020	BUY	$77.66 - $99.74 $109,422 - $140,533	1,409 New	1,409 $130,000

Others Institutions Holding EXAS

# of Institutions

673

Shares Held

162M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.3B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Belpointe Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belpointe Asset Management LLC with notifications on news.

Account

Belpointe Asset Management LLC Exact Sciences Corp Transaction History